Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Multi-pathogen infections and Alzheimer's disease

D. Vigasova, M. Nemergut, B. Liskova, J. Damborsky

. 2021 ; 20 (1) : 25. [pub] 20210128

Language English Country Great Britain

Document type Journal Article, Review

Grant support
CZ.02.1.01/0.0/0.0/16_026/0008451 Czech Ministry of Education
TN01000013 Technologická Agentura České Republiky

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with the overproduction and accumulation of amyloid-β peptide and hyperphosphorylation of tau proteins in the brain. Despite extensive research on the amyloid-based mechanism of AD pathogenesis, the underlying cause of AD is not fully understood. No disease-modifying therapies currently exist, and numerous clinical trials have failed to demonstrate any benefits. The recent discovery that the amyloid-β peptide has antimicrobial activities supports the possibility of an infectious aetiology of AD and suggests that amyloid-β plaque formation might be induced by infection. AD patients have a weakened blood-brain barrier and immune system and are thus at elevated risk of microbial infections. Such infections can cause chronic neuroinflammation, production of the antimicrobial amyloid-β peptide, and neurodegeneration. Various pathogens, including viruses, bacteria, fungi, and parasites have been associated with AD. Most research in this area has focused on individual pathogens, with herpesviruses and periodontal bacteria being most frequently implicated. The purpose of this review is to highlight the potential role of multi-pathogen infections in AD. Recognition of the potential coexistence of multiple pathogens and biofilms in AD's aetiology may stimulate the development of novel approaches to its diagnosis and treatment. Multiple diagnostic tests could be applied simultaneously to detect major pathogens, followed by anti-microbial treatment using antiviral, antibacterial, antifungal, and anti-biofilm agents.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026169
003      
CZ-PrNML
005      
20211026133142.0
007      
ta
008      
211013s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12934-021-01520-7 $2 doi
035    __
$a (PubMed)33509204
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Vigasova, Dana $u International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic $u Department of Experimental Biology and RECETOX, Faculty of Science, Loschmidt Laboratories, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
245    10
$a Multi-pathogen infections and Alzheimer's disease / $c D. Vigasova, M. Nemergut, B. Liskova, J. Damborsky
520    9_
$a Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with the overproduction and accumulation of amyloid-β peptide and hyperphosphorylation of tau proteins in the brain. Despite extensive research on the amyloid-based mechanism of AD pathogenesis, the underlying cause of AD is not fully understood. No disease-modifying therapies currently exist, and numerous clinical trials have failed to demonstrate any benefits. The recent discovery that the amyloid-β peptide has antimicrobial activities supports the possibility of an infectious aetiology of AD and suggests that amyloid-β plaque formation might be induced by infection. AD patients have a weakened blood-brain barrier and immune system and are thus at elevated risk of microbial infections. Such infections can cause chronic neuroinflammation, production of the antimicrobial amyloid-β peptide, and neurodegeneration. Various pathogens, including viruses, bacteria, fungi, and parasites have been associated with AD. Most research in this area has focused on individual pathogens, with herpesviruses and periodontal bacteria being most frequently implicated. The purpose of this review is to highlight the potential role of multi-pathogen infections in AD. Recognition of the potential coexistence of multiple pathogens and biofilms in AD's aetiology may stimulate the development of novel approaches to its diagnosis and treatment. Multiple diagnostic tests could be applied simultaneously to detect major pathogens, followed by anti-microbial treatment using antiviral, antibacterial, antifungal, and anti-biofilm agents.
650    _2
$a Alzheimerova nemoc $x farmakoterapie $x mikrobiologie $7 D000544
650    _2
$a zvířata $7 D000818
650    _2
$a antiinfekční látky $x terapeutické užití $7 D000890
650    _2
$a antivirové látky $x farmakologie $x terapeutické užití $7 D000998
650    _2
$a biofilmy $x účinky léků $7 D018441
650    _2
$a lidé $7 D006801
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Nemergut, Michal $u Department of Experimental Biology and RECETOX, Faculty of Science, Loschmidt Laboratories, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Liskova, Barbora $u Department of Experimental Biology and RECETOX, Faculty of Science, Loschmidt Laboratories, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic
700    1_
$a Damborsky, Jiri $u International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic. jiri@chemi.muni.cz $u Department of Experimental Biology and RECETOX, Faculty of Science, Loschmidt Laboratories, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. jiri@chemi.muni.cz
773    0_
$w MED00008244 $t Microbial cell factories $x 1475-2859 $g Roč. 20, č. 1 (2021), s. 25
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33509204 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133148 $b ABA008
999    __
$a ok $b bmc $g 1715010 $s 1146676
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 20 $c 1 $d 25 $e 20210128 $i 1475-2859 $m Microbial cell factories $n Microb Cell Fact $x MED00008244
GRA    __
$a CZ.02.1.01/0.0/0.0/16_026/0008451 $p Czech Ministry of Education
GRA    __
$a TN01000013 $p Technologická Agentura České Republiky
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...